ArticlePharmaceutical research2011

Actively targeted low-dose camptothecin as a safe, long-acting, disease-modifying nanomedicine for rheumatoid arthritis.

Otilia May Yue Koo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.